Skip to main content
Erschienen in: Pituitary 4/2015

01.08.2015

Endoscopic endonasal transsellar approach for laterally extended pituitary adenomas: volumetric analysis of cavernous sinus invasion

verfasst von: Masaaki Taniguchi, Kohkichi Hosoda, Nobuyuki Akutsu, Yutaka Takahashi, Eiji Kohmura

Erschienen in: Pituitary | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The authors conducted a statistical analysis of surgical results of the endoscopic endonasal transsellar approach to provide quantitative indices for selection of the approach in the treatment of laterally extended pituitary adenomas.

Methods

Surgical results of 25 patients with laterally extended pituitary adenomas of Knosp grade 3 or 4 were retrospectively analyzed. The removal rate was evaluated by the volumetric change of the lateral tumor compartment.

Results

The transsellar approach was used exclusively in all cases. Gross total removal of the lateral tumor compartment was achieved in 14 (56.0 %). Factors affecting the tumor removal through the transsellar approach were lateral tumor volume (p = 0.006), maximal distance to the cavernous sinus outer wall (p = 0.004) and history of previous surgery (p = 0.017). The cut-off values for the lateral tumor volume and maximal distance to the cavernous sinus outer wall predicting the gross total removal were 0.479 ml and 8.1 mm, respectively. The surgical complications of the transsellar approach included each case of anterior lobe function insufficiency and liquorrhea.

Conclusions

The transsellar approach is adequate for removal of lateral tumor compartment in the majority of cases with laterally extended pituitary adenomas. The tumor compartments dorsal and ventral to the horizontal portion of the intracavernous carotid artery are amenable to the removal. But for removal of the tumor compartment lateral to the carotid siphon requires additional use of the parasellar approach.
Literatur
1.
Zurück zum Zitat Zhao B, Wei YK, Li GL, Li YN, Yao Y, Kang J, Ma WB, Yang Y, Wang RZ (2010) Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J Neurosurg 112:108–117PubMedCrossRef Zhao B, Wei YK, Li GL, Li YN, Yao Y, Kang J, Ma WB, Yang Y, Wang RZ (2010) Extended transsphenoidal approach for pituitary adenomas invading the anterior cranial base, cavernous sinus, and clivus: a single-center experience with 126 consecutive cases. J Neurosurg 112:108–117PubMedCrossRef
2.
Zurück zum Zitat Ceylan S, Koc K, Anik I (2010) Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus. J Neurosurg 112:99–107PubMedCrossRef Ceylan S, Koc K, Anik I (2010) Endoscopic endonasal transsphenoidal approach for pituitary adenomas invading the cavernous sinus. J Neurosurg 112:99–107PubMedCrossRef
3.
Zurück zum Zitat Lee JY, Bohman LE, Bergsneider M (2014) Contemporary neurosurgical techniques for pituitary tumor resection. J Neurooncol 117:437–444PubMedCrossRef Lee JY, Bohman LE, Bergsneider M (2014) Contemporary neurosurgical techniques for pituitary tumor resection. J Neurooncol 117:437–444PubMedCrossRef
4.
Zurück zum Zitat McLaughlin N, Eisenberg AA, Cohan P, Chaloner CB, Kelly DF (2013) Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery. J Neurosurg 118:613–620PubMedCrossRef McLaughlin N, Eisenberg AA, Cohan P, Chaloner CB, Kelly DF (2013) Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery. J Neurosurg 118:613–620PubMedCrossRef
5.
Zurück zum Zitat Messerer M, De Battista JC, Raverot G, Kassis S, Dubourg J, Lapras V, Trouillas J, Perrin G, Jouanneau E (2011) Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus 30(4):E11PubMedCrossRef Messerer M, De Battista JC, Raverot G, Kassis S, Dubourg J, Lapras V, Trouillas J, Perrin G, Jouanneau E (2011) Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg Focus 30(4):E11PubMedCrossRef
6.
Zurück zum Zitat Raithatha R, McCoul ED, Woodworth GF, Schwartz TH, Anand VK (2012) Endoscopic endonasal approaches to the cavernous sinus. Int Forum Allergy Rhinol 2:9–15PubMedCrossRef Raithatha R, McCoul ED, Woodworth GF, Schwartz TH, Anand VK (2012) Endoscopic endonasal approaches to the cavernous sinus. Int Forum Allergy Rhinol 2:9–15PubMedCrossRef
7.
Zurück zum Zitat Woodworth GF, Patel KS, Shin B, Burkhardt JK, Tsiouris AJ, McCoul ED, Anand VK, Schwartz TH (2014) Surgical outcomes using a medial-to-lateral endonasal endoscopic approach to pituitary adenomas invading the cavernous sinus. J Neurosurg. doi:10.3171/2014.1.JNS131228 PubMedCentralPubMed Woodworth GF, Patel KS, Shin B, Burkhardt JK, Tsiouris AJ, McCoul ED, Anand VK, Schwartz TH (2014) Surgical outcomes using a medial-to-lateral endonasal endoscopic approach to pituitary adenomas invading the cavernous sinus. J Neurosurg. doi:10.​3171/​2014.​1.​JNS131228 PubMedCentralPubMed
8.
Zurück zum Zitat Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617PubMedCrossRef Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610–617PubMedCrossRef
9.
Zurück zum Zitat Taniguchi M, Kohmura E (2012) Endoscopic endonasal removal of laterally extended clival chordoma using side-viewing scopes. Acta Neurochir (Wien) 154:627–632CrossRef Taniguchi M, Kohmura E (2012) Endoscopic endonasal removal of laterally extended clival chordoma using side-viewing scopes. Acta Neurochir (Wien) 154:627–632CrossRef
10.
Zurück zum Zitat Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141–3148PubMedCrossRef Giustina A, Chanson P, Bronstein MD, Klibanski A, Lamberts S, Casanueva FF, Trainer P, Ghigo E, Ho K, Melmed S (2010) A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95:3141–3148PubMedCrossRef
11.
Zurück zum Zitat Kitano M, Taneda M, Shimono T, Nakao Y (2008) Extended transsphenoidal approach for surgical management of pituitary adenomas invading the cavernous sinus. J Neurosurg 108:26–36PubMedCrossRef Kitano M, Taneda M, Shimono T, Nakao Y (2008) Extended transsphenoidal approach for surgical management of pituitary adenomas invading the cavernous sinus. J Neurosurg 108:26–36PubMedCrossRef
12.
Zurück zum Zitat Paluzzi A, Fernandez-Miranda JC, Tonya Stefko S, Challinor S, Snyderman CH, Gardner PA (2014) Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients. Pituitary 17:307–319PubMedCrossRef Paluzzi A, Fernandez-Miranda JC, Tonya Stefko S, Challinor S, Snyderman CH, Gardner PA (2014) Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients. Pituitary 17:307–319PubMedCrossRef
13.
Zurück zum Zitat Bahuleyan B, Raghuram L, Rajshekhar V, Chacko AG (2006) To assess the ability of MRI to predict consistency of pituitary macroadenomas. Br J Neurosurg 20:324–326PubMedCrossRef Bahuleyan B, Raghuram L, Rajshekhar V, Chacko AG (2006) To assess the ability of MRI to predict consistency of pituitary macroadenomas. Br J Neurosurg 20:324–326PubMedCrossRef
14.
Zurück zum Zitat Mahmoud OM, Tominaga A, Amatya VJ, Ohtaki M, Sugiyama K, Sakoguchi T, Kinoshita Y, Takeshima Y, Ab e N, Akiyama Y, El-Ghoriany AI, Abd Alla AK, El-Sharkawy MA, Arita K, Kurisu K, Yamasaki F (2011) Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas. Eur J Radiol 80:412–417PubMedCrossRef Mahmoud OM, Tominaga A, Amatya VJ, Ohtaki M, Sugiyama K, Sakoguchi T, Kinoshita Y, Takeshima Y, Ab e N, Akiyama Y, El-Ghoriany AI, Abd Alla AK, El-Sharkawy MA, Arita K, Kurisu K, Yamasaki F (2011) Role of PROPELLER diffusion-weighted imaging and apparent diffusion coefficient in the evaluation of pituitary adenomas. Eur J Radiol 80:412–417PubMedCrossRef
15.
Zurück zum Zitat Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M (2013) Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. J Neurosurg 119:1467–1477PubMedCrossRef Hazer DB, Işık S, Berker D, Güler S, Gürlek A, Yücel T, Berker M (2013) Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria. J Neurosurg 119:1467–1477PubMedCrossRef
16.
Zurück zum Zitat Shin SS, Tormenti MJ, Paluzzi A, Rothfus WE, Chang YF, Zainah H, Fernandez-Miranda JC, Snyderman CH, Challinor SM, Gardner PA (2013) Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission. Pituitary 16:435–444PubMedCrossRef Shin SS, Tormenti MJ, Paluzzi A, Rothfus WE, Chang YF, Zainah H, Fernandez-Miranda JC, Snyderman CH, Challinor SM, Gardner PA (2013) Endoscopic endonasal approach for growth hormone secreting pituitary adenomas: outcomes in 53 patients using 2010 consensus criteria for remission. Pituitary 16:435–444PubMedCrossRef
17.
Zurück zum Zitat Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA Jr (2013) Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98:3190–3198PubMedCrossRef Starke RM, Raper DM, Payne SC, Vance ML, Oldfield EH, Jane JA Jr (2013) Endoscopic vs microsurgical transsphenoidal surgery for acromegaly: outcomes in a concurrent series of patients using modern criteria for remission. J Clin Endocrinol Metab 98:3190–3198PubMedCrossRef
18.
Zurück zum Zitat Kawamata T, Amano K, Hori T (2008) Novel flexible forceps for endoscopic transsphenoidal resection of pituitary tumors: technical report. Neurosurg Rev 31:65–68PubMedCrossRef Kawamata T, Amano K, Hori T (2008) Novel flexible forceps for endoscopic transsphenoidal resection of pituitary tumors: technical report. Neurosurg Rev 31:65–68PubMedCrossRef
19.
Zurück zum Zitat Taniguchi M, Kato A, Taki T, Tsuzuki T, Yoshimine T, Kohmura E (2011) Microsurgical Maneuvers under Side-Viewing Endoscope in the Treatment of Skull Base Lesions. Skull Base 21:115–122PubMedCentralPubMedCrossRef Taniguchi M, Kato A, Taki T, Tsuzuki T, Yoshimine T, Kohmura E (2011) Microsurgical Maneuvers under Side-Viewing Endoscope in the Treatment of Skull Base Lesions. Skull Base 21:115–122PubMedCentralPubMedCrossRef
Metadaten
Titel
Endoscopic endonasal transsellar approach for laterally extended pituitary adenomas: volumetric analysis of cavernous sinus invasion
verfasst von
Masaaki Taniguchi
Kohkichi Hosoda
Nobuyuki Akutsu
Yutaka Takahashi
Eiji Kohmura
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Pituitary / Ausgabe 4/2015
Print ISSN: 1386-341X
Elektronische ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-014-0604-7

Weitere Artikel der Ausgabe 4/2015

Pituitary 4/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.